Micafungin Completed Phase 2 Trials for Candida Meningitis / Candidiasis, Systemic Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03421002Determination of Levels of Micafungin in Neonates Suffering From Systemic Candidiasis and/or Candida Meningitis